相关实验视频
Updated: Jun 24, 2025

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
基本的宿主反应参数来分类COVID-19和社区获得性肺炎的死亡风险
Rosario Menéndez1,2,3,4, Raúl Méndez5,6,7,8, Paula González-Jiménez1,2,3
1Pneumology Department, La Fe University and Polytechnic Hospital, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.
使用简单的生物标志物来评估宿主反应,例如绝对淋巴细胞计数,C反应蛋白和SpO2 / FiO2,有助于肺炎风险分层. 这些标记物的异常与COVID-19患者的死亡率增加和ICU入院显著相关.
科学领域:
- 肺病学和重症监护医学 肺病学和重症监护医学
- 传染性疾病 传染性疾病
- 生物标志物发现和验证
背景情况:
- 准确的风险分层对于管理肺炎至关重要,包括COVID-19和社区性肺炎 (CAP).
- 目前的表型化方法可能无法完全捕捉宿主对感染的反应.
- 需要可访问和多维的方法来评估疾病的严重程度.
研究的目的:
- 为了评估宿主响应在入院时对COVID-19和CAP严重程度分层的影响.
- 评估三种易于获得的生物标志物 (绝对淋巴细胞计数,C反应蛋白,SpO2/FiO2) 在预测结果中的有用性.
主要方法:
- 三个COVID-19和一个CAP多中心队列的回顾性分析.
- 选择绝对淋巴细胞计数 (ALC),C反应蛋白 (CRP) 和SpO2/FiO2作为关键生物标志物.
- 多变量后勤回归分析以确定生物标志物水平与结果 (住院死亡率,ICU入院) 之间的关联.
主要成果:
- 观察到医院死亡率和ICU入院率的几率比率增加,COVID-19患者中异常生物标志物的数量越来越多.
- 在COVID-19中死亡率的预测模型实现了接受器运行特征曲线 (AUROC) 下的面积为0.83.
- 在CAP队列中也发现了类似的趋势,但从统计学上来说并不显著.
结论:
- 反映免疫,炎症和呼吸系统状态的可访问的生物标志物可以有效地分层肺炎的严重程度.
- 这种宿主反应评估为肺炎管理中的临床决策提供了一个简单,快速适用的方法.
- 这些发现支持使用ALC,CRP和SpO2/FiO2来加强住院肺炎患者的风险评估.
更多相关视频
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
12:27The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
相关概念视频
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...